Cardiovascular Pharmacogenomics: Expectations and Practical Benefits
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular Pharmacogenomics: Expectations and Practical Benefits
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 95, Issue 3, Pages 281-293
Publisher
Springer Nature
Online
2013-12-09
DOI
10.1038/clpt.2013.234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
- (2013) Jacqueline S. Danik et al. AMERICAN HEART JOURNAL
- Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices
- (2013) John A. Cairns CANADIAN JOURNAL OF CARDIOLOGY
- Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
- (2013) Marianne K. DeGorter et al. Circulation-Cardiovascular Genetics
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Implementing genomic medicine in the clinic: the future is here
- (2013) Teri A. Manolio et al. GENETICS IN MEDICINE
- A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals
- (2013) Aki S. Havulinna et al. HYPERTENSION
- Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: A systematic review and meta-analysis
- (2013) Jie Yang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pharmacogenetics of warfarin: challenges and opportunities
- (2013) Ming Ta Michael Lee et al. JOURNAL OF HUMAN GENETICS
- Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
- (2013) Minoli A Perera et al. LANCET
- Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality
- (2013) Kristina H. Haugaa et al. MAYO CLINIC PROCEEDINGS
- A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
- (2013) Lara M. Mangravite et al. NATURE
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema
- (2013) Guillaume Pare et al. Pharmacogenetics and Genomics
- Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis
- (2013) Seyed Hamidreza Mahmoudpour et al. PHARMACOGENOMICS
- Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
- (2013) H. J. Haiser et al. SCIENCE
- Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta 1 389 Arg/Gly Adrenergic Receptor Polymorphism
- (2013) Ryan G. Aleong et al. JACC-Heart Failure
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pharmacogenomics of warfarin in populations of African descent
- (2012) Guilherme Suarez-Kurtz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiovascular Pharmacogenomics: The Future of Cardiovascular Therapeutics?
- (2012) Dan M. Roden CANADIAN JOURNAL OF CARDIOLOGY
- Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure
- (2012) Ryan G. Aleong et al. Circulation-Arrhythmia and Electrophysiology
- Paraoxonase 1 Q192R Variant and Clopidogrel Efficacy
- (2012) Joshua P. Lewis et al. Circulation-Cardiovascular Genetics
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
- (2012) J M Pulley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug-induced arrhythmia: pharmacogenomic prescribing?
- (2012) E. R. Behr et al. EUROPEAN HEART JOURNAL
- The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes
- (2012) Elijah R. Behr et al. EUROPEAN HEART JOURNAL
- CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome
- (2012) Thomas Cuisset et al. JACC-Cardiovascular Interventions
- Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia
- (2012) Yalda Jamshidi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-analysis identifies six new susceptibility loci for atrial fibrillation
- (2012) Patrick T Ellinor et al. NATURE GENETICS
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes
- (2012) A H Ramirez et al. PHARMACOGENOMICS JOURNAL
- β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
- (2012) Wen-Nan Liu et al. PLoS One
- ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
- (2012) Jia Su et al. PLoS One
- Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms
- (2012) Christopher M. O'Connor et al. PLoS One
- Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleeding
- (2012) Thomas M. Polasek et al. THROMBOSIS AND HAEMOSTASIS
- KCNEgenetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?
- (2012) Geoffrey W Abbott Expert Review of Clinical Pharmacology
- A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes
- (2011) Stefan Kääb et al. Circulation-Cardiovascular Genetics
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
- (2011) Jeffrey J.W. Verschuren et al. EUROPEAN HEART JOURNAL
- Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
- (2011) Michel Zabalza et al. HEART
- Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals
- (2011) Andrew D. Johnson et al. HYPERTENSION
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients
- (2011) Y. LI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
- (2011) Andrew L. Mammen et al. ARTHRITIS CARE & RESEARCH
- Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry
- (2010) Nicholas L. Smith et al. Circulation-Cardiovascular Genetics
- Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
- (2010) P.-C. Cha et al. HUMAN MOLECULAR GENETICS
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- VKORC1 Pharmacogenomics Summary
- (2010) Ryan P. Owen et al. Pharmacogenetics and Genomics
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- An α 2C -Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the β-Blocker Bucindolol in Chronic Heart Failure
- (2009) Michael R. Bristow et al. Circulation-Heart Failure
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
- (2008) MA Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
- (2008) Stephen B Liggett et al. NATURE MEDICINE
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search